The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib.
Lahera A, Vela-Martín L, Fernández-Navarro P, Llamas P, López-Lorenzo JL, Cornago J, Santos J, Fernández-Piqueras J, Villa-Morales M.
Lahera A, et al. Among authors: fernandez piqueras j.
Mol Carcinog. 2024 Jan;63(1):5-10. doi: 10.1002/mc.23632. Epub 2023 Sep 15.
Mol Carcinog. 2024.
PMID: 37712558